Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Kaltenmeier

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|May 31, 2018
Radioembolization for Hepatocellular Carcinoma: A Nationwide 10-Year ExperienceSamer Tohme, Patrick Bou Samra, Christof Kaltenmeier, et al.
The American Surgeon|November 12, 2021
Impact of Metformin Use on Survival in Patients Undergoing Liver Resection for Colorectal Cancer MetastasesChristof Kaltenmeier, Brittany Morocco, Hamza Yazdani, et al.
The American Surgeon|December 21, 2020
Pathologic Complete Response Following Neoadjuvant Therapy for Gastric Adenocarcinoma: A National Cancer Database Analysis on Incidence, Predictors, and OutcomesChristof Kaltenmeier, Alison Althans, Maria Mascara, et al.
Annals of Surgery|December 19, 2019
Time to Surgery and Colon Cancer Survival in the United StatesChristof Kaltenmeier, Chengli Shen, David S Medich, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 15, 2020
The liver transplant risk score prognosticates the outcomes of liver transplant recipients at listingChristof Kaltenmeier, Dana Jorgensen, Stalin Dharmayan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 7, 2023
Living donor liver transplantation for colorectal cancer liver metastases: Midterm outcomes at a single center in North AmericaChristof Kaltenmeier, David A Geller, Swaytha Ganesh, et al.
BJS Open|June 5, 2024
Survival after live donor versus deceased donor liver transplantation: propensity score-matched studyChristof Kaltenmeier, Hao Liu, Xingyu Zhang, et al.
The American Surgeon|February 1, 2021
Readmission After Surgical Resection for Colon and Rectal Cancers: A Retrospective Cohort StudySidrah Khan, Christof Kaltenmeier, Katherine Hrebinko, et al.
The American Surgeon|December 28, 2020
Readmission After Surgical Resection and Transplantation for Hepatocellular Carcinoma: A Retrospective Cohort StudySidrah Khan, Alexis Chidi, Katherine Hrebinko, et al.
Biochemical and Biophysical Research Communications|January 29, 2020
MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1Kun Dong, Qiang Du, Xiao Cui, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Journal of Vascular and Interventional Radiology : JVIR|May 31, 2018
Radioembolization for Hepatocellular Carcinoma: A Nationwide 10-Year ExperienceSamer Tohme, Patrick Bou Samra, Christof Kaltenmeier, et al.
The American Surgeon|November 12, 2021
Impact of Metformin Use on Survival in Patients Undergoing Liver Resection for Colorectal Cancer MetastasesChristof Kaltenmeier, Brittany Morocco, Hamza Yazdani, et al.
The American Surgeon|December 21, 2020
Pathologic Complete Response Following Neoadjuvant Therapy for Gastric Adenocarcinoma: A National Cancer Database Analysis on Incidence, Predictors, and OutcomesChristof Kaltenmeier, Alison Althans, Maria Mascara, et al.
Annals of Surgery|December 19, 2019
Time to Surgery and Colon Cancer Survival in the United StatesChristof Kaltenmeier, Chengli Shen, David S Medich, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 15, 2020
The liver transplant risk score prognosticates the outcomes of liver transplant recipients at listingChristof Kaltenmeier, Dana Jorgensen, Stalin Dharmayan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 7, 2023
Living donor liver transplantation for colorectal cancer liver metastases: Midterm outcomes at a single center in North AmericaChristof Kaltenmeier, David A Geller, Swaytha Ganesh, et al.
BJS Open|June 5, 2024
Survival after live donor versus deceased donor liver transplantation: propensity score-matched studyChristof Kaltenmeier, Hao Liu, Xingyu Zhang, et al.
The American Surgeon|February 1, 2021
Readmission After Surgical Resection for Colon and Rectal Cancers: A Retrospective Cohort StudySidrah Khan, Christof Kaltenmeier, Katherine Hrebinko, et al.
The American Surgeon|December 28, 2020
Readmission After Surgical Resection and Transplantation for Hepatocellular Carcinoma: A Retrospective Cohort StudySidrah Khan, Alexis Chidi, Katherine Hrebinko, et al.
Biochemical and Biophysical Research Communications|January 29, 2020
MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1Kun Dong, Qiang Du, Xiao Cui, et al.
Pageof 6